A STAT investigation of the fertility tourism industry found that clinics are offering an unproven IVF procedure to older women. Here are 5 takeaways from the investigation.
Voters in 2026 midterm elections decided state health policy ballot measures on abortion rights, marijuana laws, science bonds, and transgender youth care.
With research on abortion access barriers, STAT Wunderkind Betsy Pleasants is defining a framework for using AI tools without losing sight of the people behind the data.
The FDA says its ongoing safety review of the nation's main abortion pill will continue into next year, a timeline that was quickly condemned by abortion opponents.
Heidi Overton, nominee for commissioner of the Food and Drug Administration, avoided directly addressing her views on mifepristone during a Senate health committee meeting. As CEO of Reproductive Futures, a legal organization advocating for reproductive rights, the author expresses concern that Overton's anti-abortion views could lead to harmful policies if she becomes FDA commissioner.
Heidi Overton, President Trump's nominee to lead the FDA, was questioned by senators on topics including China, vaccines, and abortion access during her committee hearing. Overton, a preventive medicine physician from New Mexico, repeatedly referred to existing FDA guidance and approvals without revealing her personal stance on updating or altering them.
“A click, signature, or brief review should not magically transfer responsibility from an AI developer or platform to a physician,” a reader tells STAT.